Puma Biotechnology Inc’s recently made public that its Director MILLER MICHAEL PATRICK unloaded Company’s shares for reported $81466.0 on Aug 12 ’24. In the deal valued at $3.49 per share,23,358 shares were sold. As a result of this transaction, MILLER MICHAEL PATRICK now holds 47,000 shares worth roughly $0.12 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, MILLER MICHAEL PATRICK bought 23,358 shares, generating $87,826 in total proceeds.
Before that, NOUGUES MAXIMO F sold 4,156 shares. Puma Biotechnology Inc shares valued at $15,382 were divested by the Chief Financial Officer at a price of $3.70 per share. As a result of the transaction, NOUGUES MAXIMO F now holds 162,522 shares, worth roughly $0.43 million.
Citigroup upgraded its Puma Biotechnology Inc [PBYI] rating to a Buy from a a Neutral in a research note published recently. Goldman also remained covering PBYI and has decreased its forecast on October 08, 2019 with a “Sell” recommendation from previously “Neutral” rating. Citigroup revised its rating on May 10, 2019. It rated PBYI as “a Neutral” which previously was an “a Buy”.
Price Performance Review of PBYI
On Monday, Puma Biotechnology Inc [NASDAQ:PBYI] saw its stock jump 4.33% to $2.65. Over the last five days, the stock has lost -6.36%. Puma Biotechnology Inc shares have fallen nearly -38.80% since the year began. Nevertheless, the stocks have fallen -29.33% over the past one year. While a 52-week high of $7.73 was reached on 02/15/24, a 52-week low of $2.13 was recorded on 08/14/24. SMA at 50 days reached $3.30, while 200 days put it at $4.41.
Levels Of Support And Resistance For PBYI Stock
The 24-hour chart illustrates a support level at 2.50, which if violated will result in even more drops to 2.35. On the upside, there is a resistance level at 2.75. A further resistance level may holdings at 2.85. The Relative Strength Index (RSI) on the 14-day chart is 38.30, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.48, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 85.06%. Stochastics %K at 8.81% indicates the stock is a buying.
How much short interest is there in Puma Biotechnology Inc?
A steep rise in short interest was recorded in Puma Biotechnology Inc stocks on 2024-07-31, growing by 0.89 million shares to a total of 3.82 million shares. Yahoo Finance data shows the prior-month short interest on 2024-06-28 was 2.93 million shares. There was a rise of 23.37%, which implies that there is a positive sentiment for the stock.
